Abstract:Numerous molecular and physiological processes in the skeletal muscle undergo circadian time-dependent oscillations in accordance with daily activity/rest cycles. The circadian regulatory mechanisms underlying these cyclic processes, especially at the post-transcriptional level, are not well defined. Previously, we reported that the circadian E3 ligase FBXL21 mediates rhythmic degradation of the sarcomere protein TCAP in conjunction with GSK-3β, and Psttm mice harboring an Fbxl21 hypomorph allele show reduced muscle fiber diameter and impaired muscle function. To further elucidate the regulatory function of FBXL21 in skeletal muscle, we investigated another sarcomere protein, Myozenin1 (MYOZ1), that we identified as an FBXL21-binding protein from yeast 2-hybrid screening. We show that FBXL21 binding to MYOZ1 led to ubiquitination-mediated proteasomal degradation. GSK-3β co-expression and inhibition were found to accelerate and decelerate FBXL21-mediated MYOZ1 degradation, respectively. Previously, MYOZ1 has been shown to inhibit calcineurin/NFAT signaling important for muscle differentiation. In accordance, Fbxl21 KO and MyoZ1 KO in C2C12 cells impaired and enhanced myogenic differentiation respectively compared with control C2C12 cells, concomitant with distinct effects on NFAT nuclear localization and NFAT target gene expression. Importantly, in Psttm mice, both the levels and diurnal rhythm of NFAT2 nuclear localization were significantly diminished relative to wild-type mice, and circadian expression of NFAT target genes associated with muscle differentiation was also markedly dampened. Furthermore, Psttm mice exhibited significant disruption of sarcomere structure with a considerable excess of MYOZ1 accumulation in the Z-line. Taken together, our study illustrates a pivotal role of FBXL21 in sarcomere structure and muscle differentiation by regulating MYOZ1 degradation and NFAT2 signaling. Skeletal muscle is a vital organ for our mobility, metabolism, and health. It is also highly dynamic at the molecular level, yet the underlying regulatory mechanisms are not well understood. Mounting evidence suggests a critical role of the biological timer, called circadian clock, in the molecular flux during the daily activity/rest cycle. Our previous research has revealed a circadian E3 ubiquitin ligase, FBXL21, as a regulator in the skeletal muscle. In the current study, we provide molecular and genetic evidence that FBXL21, with its upstream regulator GSK-3β, regulates degradation of a sarcomere protein, MYOZ1. Consistent with a key regulatory function, FBXL21 deficiency in Psttm mice and C2C12 cells led to marked abnormalities in muscle differentiation and function. Mechanistically, we show that FBXL21 and MYOZ1 regulate diurnal NFAT nuclear translocation and activity, a pathway important for muscle differentiation and development. Together, our work establishes a critical role of the circadian E3 ligase FBXL21 in muscle differentiation and sarcomere structure by regulating MYOZ1 and NFAT signaling.

The GSK-3β-FBXL21 Axis Contributes to Circadian TCAP Degradation and Skeletal Muscle Function

The circadian E3 ligase FBXL21 regulates myoblast differentiation and sarcomere architecture via MYOZ1 ubiquitination and NFAT signaling

The Skeletal Muscle Circadian Clock Regulates Titin Splicing Through RBM20

Mmp14 is required for matrisome homeostasis and circadian rhythm in fibroblasts

CRY Drives Cyclic CK2-Mediated BMAL1 Phosphorylation to Control the Mammalian Circadian Clock

Circadian Metabolic Regulation Through Crosstalk Between Casein Kinase 1δ and Transcriptional Coactivator PGC-1α

Circadian clock control of MRTF/SRF pathway suppresses beige adipocyte thermogenic recruitment

SCFβ-TRCP Controls Clock-dependent Transcription via Casein Kinase 1-dependent Degradation of the Mammalian Period-1 (Per1) Proteinm

Necdin regulates BMAL1 stability and circadian clock through SGT1-HSP90 chaperone machinery

The endogenous molecular clock orchestrates the temporal separation of substrate metabolism in skeletal muscle

Muscle-specific loss of Bmal1 leads to disrupted tissue glucose metabolism and systemic glucose homeostasis

Circadian Clock in Muscle Disease Etiology and Therapeutic Potential for Duchenne Muscular Dystrophy

308-OR: The Circadian Clock Exerts Coordinated Control of Beige Adipocyte Development via Cytoskeleton-MRTF/SRF Signaling Cascade

Circadian mutant Overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression.

Molecular mechanisms of GSK3β-driven modulation of ABLIM1 and titin interactions in cardiac muscle

Circadian Rhythms, the Molecular Clock, and Skeletal Muscle

VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle

Cryptochrome Mediates Circadian Regulation of Camp Signaling and Hepatic Gluconeogenesis

Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function

Dual Roles of FBXL3 in the Mammalian Circadian Feedback Loops Are Important for Period Determination and Robustness of the Clock

CUL4-DDB1-CDT2 E3 Ligase Regulates the Molecular Clock Activity by Promoting Ubiquitination-Dependent Degradation of the Mammalian CRY1